In addition to these likely pathogenic variants we also detected somatic variants within known cancer genes including BUB1, MSH2, and KIT. However in each example the variants occurred outside known hot spots and critical protein domains, involved conserved amino acid changes, or have been predicted to be non-pathogenic [21, 22]. Here, MSH2 is linked to cancer.